Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Market Cap : €4,317.9 Mil (As of May. 01, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Laboratorios Farmaceuticos Rovi's share price for the quarter that ended in Dec. 2023 was €60.2. Laboratorios Farmaceuticos Rovi's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 51.8 Mil. Therefore, Laboratorios Farmaceuticos Rovi's market cap for the quarter that ended in Dec. 2023 was €3,119.6 Mil.

Laboratorios Farmaceuticos Rovi's quarterly market cap increased from Jun. 2023 (€2,259.7 Mil) to Sep. 2023 (€2,721.9 Mil) and increased from Sep. 2023 (€2,721.9 Mil) to Dec. 2023 (€3,119.6 Mil).

Laboratorios Farmaceuticos Rovi's annual market cap declined from Dec. 2021 (€4,045.4 Mil) to Dec. 2022 (€1,888.5 Mil) but then increased from Dec. 2022 (€1,888.5 Mil) to Dec. 2023 (€3,119.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Laboratorios Farmaceuticos Rovi's Enterprise Value for Today is €4,358.0 Mil.

Laboratorios Farmaceuticos Rovi Market Cap Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Market Cap Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,351.32

2,099.48

4,045.40

1,888.53

3,119.57

Laboratorios Farmaceuticos Rovi Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															1,888.53	2,015.07	2,259.67	2,721.95	3,119.57

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Market Cap

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Market Cap distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Market Cap falls into.

Laboratorios Farmaceuticos Rovi Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Laboratorios Farmaceuticos Rovi's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	€60.2	*	51.8201
	=	€3,119.6

Laboratorios Farmaceuticos Rovi's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	€60.2	*	51.8201
	=	€3,119.6

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Laboratorios Farmaceuticos Rovi Market Cap Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.